Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81


Vascular Graft Bridged En Bloc Resection for Biliopancreatic Cancer Invading the Portal System.

Lai YG, Gao Y, Liu JG, Lyu W, Sun H, Cheng D, Yang S, Liu JX, Duan WH.

Chin Med J (Engl). 2017 Sep 20;130(18):2259-2260. doi: 10.4103/0366-6999.213977. No abstract available.


Using Attenuated Total Reflection-Fourier Transform Infra-Red (ATR-FTIR) spectroscopy to distinguish between melanoma cells with a different metastatic potential.

Minnes R, Nissinmann M, Maizels Y, Gerlitz G, Katzir A, Raichlin Y.

Sci Rep. 2017 Jun 29;7(1):4381. doi: 10.1038/s41598-017-04678-6.


Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival.

Lu F, Soares KC, He J, Javed AA, Cameron JL, Rezaee N, Pawlik TM, Wolfgang CL, Weiss MJ.

Hepatobiliary Surg Nutr. 2017 Jun;6(3):144-153. doi: 10.21037/hbsn.2016.08.06.


Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer.

Hitchcock KE, Nichols RC, Morris CG, Bose D, Hughes SJ, Stauffer JA, Celinski SA, Johnson EA, Zaiden RA, Mendenhall NP, Rutenberg MS.

World J Gastrointest Surg. 2017 Apr 27;9(4):103-108. doi: 10.4240/wjgs.v9.i4.103.


A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.

Elshaer M, Gravante G, Kosmin M, Riaz A, Al-Bahrani A.

Ann R Coll Surg Engl. 2017 Feb;99(2):101-106. doi: 10.1308/rcsann.2016.0340. Epub 2016 Nov 21. Review.


Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.

Dal Molin M, Brant A, Blackford AL, Griffin JF, Shindo K, Barkley T, Rezaee N, Hruban RH, Wolfgang CL, Goggins M.

PLoS One. 2016 Oct 12;11(10):e0164195. doi: 10.1371/journal.pone.0164195. eCollection 2016.


Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome?

Lahat G, Lubezky N, Gerstenhaber F, Nizri E, Gysi M, Rozenek M, Goichman Y, Nachmany I, Nakache R, Wolf I, Klausner JM.

World J Surg Oncol. 2016 Sep 29;14(1):254.


Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.

Sierzega M, Bobrzyński Ł, Matyja A, Kulig J.

World J Surg Oncol. 2016 Sep 20;14(1):248. doi: 10.1186/s12957-016-1005-3.


Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Åkerberg D, Ansari D, Andersson R.

World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424. Review.


Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach.

Xia BT, Habib DA, Dhar VK, Levinsky NC, Kim Y, Hanseman DJ, Sutton JM, Wilson GC, Smith M, Choe KA, Sussman JJ, Ahmad SA, Abbott DE.

Ann Surg Oncol. 2016 Dec;23(13):4156-4164. Epub 2016 Jul 26.


MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection.

Nguyen HV, Gore J, Zhong X, Savant SS, Deitz-McElyea S, Schmidt CM, House MG, Korc M.

J Gastrointest Surg. 2016 Oct;20(10):1699-706. doi: 10.1007/s11605-016-3208-x. Epub 2016 Jul 25.


Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome.

Baldwin S, Kukar M, Gabriel E, Attwood K, Wilkinson N, Hochwald SN, Kuvshinoff B.

HPB (Oxford). 2016 Jun;18(6):523-8. doi: 10.1016/j.hpb.2016.02.004.


Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study.

Amini N, Kim Y, Wilson A, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM.

Ann Surg Oncol. 2016 Sep;23(9):3016-23. doi: 10.1245/s10434-016-5243-y. Epub 2016 May 5.


Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.

Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Medicine (Baltimore). 2016 May;95(18):e3582. doi: 10.1097/MD.0000000000003582.


A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.

Dasari BV, Roberts KJ, Hodson J, Stevens L, Smith AM, Hubscher SG, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R, Mirza DF.

HPB (Oxford). 2016 Apr;18(4):332-8. doi: 10.1016/j.hpb.2015.11.008. Epub 2016 Feb 24.


Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

Kang CM, Lee SH, Hwang HK, Yun M, Lee WJ.

Medicine (Baltimore). 2016 Mar;95(9):e2595. doi: 10.1097/MD.0000000000002595.


Long-term survival in patients with pancreatic ductal adenocarcinoma.

Stark AP, Sacks GD, Rochefort MM, Donahue TR, Reber HA, Tomlinson JS, Dawson DW, Eibl G, Hines OJ.

Surgery. 2016 Jun;159(6):1520-1527. doi: 10.1016/j.surg.2015.12.024. Epub 2016 Feb 2.


Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.

Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V.

Ann Surg Oncol. 2016 Jun;23(6):2010-8. doi: 10.1245/s10434-016-5093-7. Epub 2016 Jan 29.


The lymphatic system and pancreatic cancer.

Fink DM, Steele MM, Hollingsworth MA.

Cancer Lett. 2016 Oct 10;381(1):217-36. doi: 10.1016/j.canlet.2015.11.048. Epub 2015 Dec 29. Review.


Supplemental Content

Support Center